Northwest Biotherapeutics | NWBO - أصول متداولة





أصول متداولة تغيير تاريخ
Agenus USD 133.44M 514K 2025-12
AstraZeneca USD 28.72B 1.22B 2025-12
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Celldex Therapeutics USD 534.66M 69.68M 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Infinity Pharmaceuticals USD 19.91M 8.46M 2023-06
Merck USD 47.56B 10.49B 2025-09
Northwest Biotherapeutics USD 7.2M 1.04M 2025-09
Pfizer USD 46.92B 3.22B 2025-09
Plus Therapeutics USD 15.17M 2.42M 2025-12
Roche Holding CHF 38.73B 3.03B 2025-12